Komori
Daicel (4202) · InitiativeAdvanced

Expanding and strengthening global business operations

First written in FY2016. 14 of 19 entries say "Advanced", first in FY2017-Q2. Latest entry: 2026-11-05.

19entries
11years
3from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2019 – FY2023RestatedFY20242016: 220162017: 220172018: 220182019: 320192020: 120202021: 120212022: 120222023: 220232024: 120242025: 020252026: 42026
Same theme, other companies
Expansion of the overseas business strategyA theme 47 companies write about · 0 as a headwind · 47 as a tailwind

16 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 47 companies compared. The sentences above are computed from all 47.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Steadily capture growth markets, including China and India, by leveraging expanded supply capacity and local materials and market development capabilities.」

    Regarding global expansion, the company is formulating a specific policy to leverage China and India as growth markets, together with its expanded supply capacity and local materials and market development capabilities.
  2. 2026-05-22AdvancedEarnings presentation

    「現地材料・市場開発体制で成長市場(中国・インド)を着実に刈り取り」

    グローバル展開について、中国・インドでの現地開発・市場開発体制を通じた拡販を具体化した。
  3. FY2024RestatedAnnual report

    「To promote global market expansion, we will strengthen our network with five overseas Technical Solution Centers and, particularly in the Chinese market, pursue the creation of new-market development projects and advance concept proposals.」

    The company continues to develop new markets and pursue proposal activities using its five overseas Technical Solution Centers.
  4. FY2023AdvancedAnnual report

    「Expand sales in Western markets (10% share in Western markets for polyacetal resin (POM) and liquid-crystal polymer (LCP))」

    Regarding the global expansion of the engineering plastics business, the company indicated a specific target of a 10% share in Western markets for POM and LCP, in addition to expanding sales in those markets.
  5. FY2023-Q3AdvancedAnnual report

    「As the conditions under the agreement had been satisfied on 26 December 2022, we accepted the investment on 10 January 2023.」

    For global expansion, the conditions of the joint venture agreement concerning the holding company established by Polyplastics’ subsidiary, DP Engineering Plastics (Nantong) Co., Ltd., were satisfied, and the company advanced to the stage of accepting a 30% investment from Global Polyacetal Co., Ltd.
  6. FY2022AdvancedAnnual report

    「To promote expansion in global markets, we are establishing a network of five overseas Technical Solution Centers and advancing the creation of new market development projects and the proposal of concepts.」

    For global expansion, the company has given concrete form to a network structure comprising 5 overseas Technical Solution Centers and to new market development and proposal activities.
  7. FY2021AdvancedAnnual report

    「Accelerating Polyplastics’ global expansion (capacity expansion investment to capture future demand and increasing sales in the European and US markets)」

    Following the acquisition of Polyplastics as a wholly owned subsidiary, the company identified capacity expansion investment and increased sales in the European and US markets as concrete measures for overseas expansion.
  8. FY2020-Q3AdvancedAnnual report

    「We decided to transfer some products from Japan and the United States to Thailand and China, where they would be more competitive.」

    The company decided to reorganize production locations by transferring some automotive safety components from Japan and the United States to Thailand and China, giving concrete form to the reorganization of its global business platform.
  9. FY2020-Q1AdvancedAnnual report

    「Effective 1 April 2019, we integrated our consolidated subsidiaries Daicel Safety Systems America, LLC, Daicel Safety Systems America Arizona, Inc., Special Devices, Inc. and 3 other companies, and established Daicel Safety Systems Americas, Inc.」

    The US consolidated subsidiaries and other entities were integrated to establish a new company, reorganizing and strengthening the organizational platform for overseas operations.
  10. FY2019AdvancedAnnual report

    「October 2018: Established Daicel Safety Systems India Pvt. Ltd. in India. (Sales of inflators for automotive airbags)」

    A company selling inflators for automotive airbags was established in India, expanding the overseas business platform.
  11. FY2019-Q3RestatedAnnual report

    「Effective 1 August 2018, we acquired Lomapharm, a German contract pharmaceutical development and manufacturing company comprising LOMA Holding GmbH, Lomapharm Rudolf Lohmann GmbH KG and Lomapharm Verwaltungs GmbH. Going forward, we will work closely with Lomapharm to accelerate growth in the medical field, which we have positioned as one of the pillars of our new business areas.」

    The company continues to disclose overseas business expansion through the acquisition of a German company.
  12. FY2019-Q2AdvancedAnnual report

    「Effective 1 August 2018, we acquired Lomapharm, a German contract pharmaceutical development and manufacturing company comprising LOMA Holding GmbH, Lomapharm Rudolf Lohmann GmbH KG and Lomapharm Verwaltungs GmbH. Going forward, we will work closely with Lomapharm to accelerate growth in the medical field, which we have positioned as one of the pillars of our new business areas. Effective 13 September 2018, we established Daicel Micro Optics Co. Ltd. in Taiwan as a base for the design, development and sale of optical products using our internally developed wafer-level lenses. We will seek to expand and accelerate the optical products business by capturing advanced needs and conducting development closely aligned with customers.」

    The acquisition of a German company and establishment of a base in Taiwan for optical product development and sales concretely expanded the overseas platform for the medical and optical products businesses.
  13. FY2018RestatedAnnual report

    「We will continue to provide solutions in response to the diversifying needs of society, including constantly evolving technologies, further globalization, and the pursuit of safety, security and health」

    The company continues to pursue a direction of international business expansion, including further globalization.
  14. FY2017RestatedAnnual report

    「We will continue to provide solutions in response to the diversifying needs of society, including constantly evolving technologies, further globalization, and the pursuit of safety, security and health」

    As a premise of 3D-III, the company positions further globalization as an ongoing direction for business operations.
  15. FY2017-Q3AdvancedAnnual report

    「From the current third quarter of the consolidated fiscal year, Daicel Safety Technologies (Jiangsu) Co., Ltd. has been included in the scope of consolidation following its establishment.」

    A new company in Jiangsu, China was added to the scope of consolidation from the third quarter, expanding the corporate platform for overseas operations.
  16. FY2017-Q2AdvancedAnnual report

    「From the current second quarter of the consolidated fiscal year, Daicel ChemTech, Inc. and Daicel Safety Systems America Holdings, Inc. have been included in the scope of consolidation following their establishment.」

    Two new companies were established in the United States and added to the scope of consolidation, advancing the development of a concrete corporate platform for overseas business expansion.
  17. FY2016First statedAnnual report

    「“Expanding and strengthening global business operations”」

    The company indicates a direction of expanding its overseas businesses in China and Asia, North America, Europe and other regions.
Moved together

"Profit allocation combining performance-linked dividends and retained earnings" moved the same way as this thread, in the same document, in 10 of its 19 moves.

1099888★123456
  1. ★This thread
  2. 1Profit allocation combining performance-linked dividends and retained earnings10×
  3. 2Building the healthcare business9×
  4. 3Enhancing the competitiveness of equipment-based industries through production innovation methods9×
  5. 4Strengthening Technology and Product Discovery and Commercialization Capabilities8×
  6. 5Development of functional materials in the electronics and medical fields8×
  7. 6Reinvestment of retained earnings in research and development and capital expenditure8×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Daicel's next results are scheduled for 2026-11-05. Read the earnings preview It last moved in the Earnings presentation of 2026-11-05: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.